Operate a franchise model for out-of-home waxing services. Provide body and facial waxing services to customers. Now — the numbers.
The biggest line carries real weight, but it doesn’t decide everything on its own.
This is an established company with proven profits.
No real growth (3% a year).
The gap is $306.2M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 36.8× for every dollar this company earns in a year — a price that already assumes things go well.
Analysts' average target sits 37% above today's price.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
An investor who bought at the very peak is down 82% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.
Over the last 5 years, sales grew only 3% a year on average. At this size, speeding back up is not easy.
The company’s market value is 37 times its annual profit. Even a small disappointment could hit the price hard.
Over the last 12 months, executives reported 33 sells against just 8 buys. Not an alarm bell by itself, but a number worth watching.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.